IP Library Granted Patent US 11,299,756
Granted Patent B2
US 11,299,756 · App. 16/739,522 · Granted Apr 12, 2022

Therapeutic serum obtained from co-cultured cells

Inventor: Walter De Paula Neto (Lavalette, WV)
Assignee: SERUCELL CORPORATION
C12P1/00A61K8/671A61K8/676A61K8/981A61K9/0014A61K9/145A61K31/137A61K31/198A61K31/201A61K31/375A61K31/573A61K31/685A61K35/12A61K45/06A61Q19/00A61Q19/08C12N5/0018C12N5/0081C12N5/0629C12N5/0652A61K2800/10A61K2800/70C12N2500/30C12N2502/1323
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,299,756
App. No.
16/739,522
Granted
Apr 12, 2022
Kind
B2
Abstract

A therapeutic serum suitable for inclusion in a cosmetic preparation may be produced by stressing a co-culture including proliferative cells. The co-culture of cells may be obtained by growing first culture to less than one-hundred percent confluence on a surface. After a monolayer of first culture is established, a second culture may be seeded onto at least one cell free area on the surface, the resulting co-culture grown to less than one-hundred percent confluence. Additional cultures may then be seeded onto cell free areas of the surface and established until a monolayer having the desired population of cells is obtained. The monolayer is then stressed to obtain a serum by conditioning a collection medium. The obtained serum may be combined with a suitable cosmetic base to provide a cosmetic preparation.

Claims (9)

1. A method for producing a serum, comprising:

i) establishing a co-culture comprising at least first cells of a first cell type and at least second cells of a second cell type, wherein both of the first cells and the second cells are proliferating in a co-culturing medium comprising at least one growth factor supporting proliferation of the first cells and at least one growth factor supporting proliferation of the second cells;

ii) replacing the co-culturing medium with a collection medium that lacks the at least one growth factor and continuing the co-culture of the first cells and second cells;

iii) after a period of continuing the co-culture, collecting at least a portion of the collection medium, wherein the collection medium in which the first and second cells have been co-cultured is the serum.

2. The method of claim 1 , wherein the continuing co-culture in step (ii) applies a stress to at least one of the first or second cells.

3. The method of claim 1 , in which the first cell type is a fibroblast cell type and the second cell type is a keratinocyte cell type.

4. The method of claim 2 , in which the first cell type is a fibroblast cell type and the second cell type is a keratinocyte cell type.

5. The method of claim 2 , in which the stress is omission from the collection medium of at least one growth factor present in the co-culturing medium.

6. The method of claim 4 , in which the stress is omission from the collection medium of at least one growth factor present in the co-culturing medium.

Assignments (2)
CHANGE OF NAME Recorded Oct 27, 2025
From: SERUCELL CORPORATION
To: SERUCELLBIO, INC.
Reel/Frame 073267/0972 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 10, 2020
From: NETO, WALTER DE PAULA
To: SERUCELL CORPORATION
Reel/Frame 051478/0834 →
Continuity (5)
Continuation 15943320 · Apr 2, 2018
Continuation In Part 15700895 · Sep 11, 2017
Continuation In Part 14597796 · Jan 15, 2015
Provisional Application 61927674 · Jan 15, 2014
Related Publication 20200149072A1 · May 14, 2020